Victoza and Pomalyst drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Victoza (liraglutide) and Pomalyst (pomalidomide). Common drug interactions include constipation among females and pruritus among males.

The phase IV clinical study analyzes what interactions people have when they take Victoza and Pomalyst. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.

What is Pomalyst?

Pomalyst has active ingredients of pomalidomide. eHealthMe is studying from 80,400 Pomalyst users. Check the latest studies of Pomalyst.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

62 people who take Victoza and Pomalyst together, and have interactions are studied.

What are the common drug interactions of Victoza and Pomalyst, by gender? *:

female:

Constipation
Fatigue (feeling of tiredness)
Headache (pain in head)
Diarrhoea
Pneumonia
Neuropathy peripheral (surface nerve damage)
Pulmonary embolism (blockage of the main artery of the lung)
Back pain
Blood glucose increased
Limb discomfort (discomfort in leg)

male:

Pruritus (severe itching of the skin)
Infection
Cataract (clouding of the lens inside the eye)
Fatigue (feeling of tiredness)
Full blood count increased
White blood cell count decreased
Death
Drug ineffective
Eye swelling
Malaise (a feeling of general discomfort or uneasiness)

What are the common drug interactions of Victoza and Pomalyst, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Arthropathy
Cataract (clouding of the lens inside the eye)
Full blood count increased
White blood cell count decreased
Blood glucose increased
Death
Infection
Plasma cell myeloma (cancer that begins in plasma cells)
Pneumonia
Renal failure acute (rapid kidney dysfunction)

60+:

Pruritus (severe itching of the skin)
Death
Muscle spasms (muscle contraction)
Pulmonary embolism (blockage of the main artery of the lung)
Respiratory failure (inadequate gas exchange by the respiratory system)
Respiratory syncytial virus infection (viral disease of respiratory system)
Seasonal allergy (allergic condition due to certain season)
Anaemia (lack of blood)
Blood iron decreased
Constipation

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 62 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Victoza and Pomalyst?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously